Oura is an always-on health intelligence platform designed to transform how people understand and manage their health in everyday life. Oura was built to give the body a voice—translating physiological signals across sleep, activity, readiness, stress, heart health, metabolic health, and women’s health into more than 50 metrics and predictive insights. In the third quarter of fiscal 2026, Paid Members wore Oura Ring for a median of approximately 23 hours per day, enabling continuous data capture that can help our members understand their bodies, recognize patterns early, and act with greater intention and precision. Health is personal, and members come to Oura at different stages of their journey—whether building habits to support sustainable weight loss, tracking response to treatment, optimizing training and recovery, or monitoring heart health for longevity. Many arrive with a specific need but expand their use over time as their priorities evolve. Oura is not a point solution for one season of life—it is a long-term health companion that links each health chapter into a unified, longitudinal experience, carrying forward what it has learned and building deeper trust over time.
Terms from the governing filing for this registration; not a claim that the offering is open today.
Underwriters: Goldman Sachs & Co. LLC, Canaccord Genuity, Needham & Company, Raymond James, Rothschild & Co, Truist Securities, William Blair, Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC, Jefferies LLC, BofA Securities, Inc., Morgan Stanley, Barclays Capital Inc., Wells Fargo Securities, LLC, Citizens JMP Securities, LLC, KeyBanc Capital Markets Inc., Guggenheim Securities, LLC, Canaccord Genuity LLC, Needham & Company, LLC, Raymond James & Associates, Inc., Rothschild & Co Global Markets Solutions LLC, Truist Securities, Inc., J.P. Morgan, William Blair & Company, L.L.C., Jefferies, BofA Securities, Barclays, Wells Fargo Securities, Citizens Capital Markets, KeyBanc Capital Markets, Guggenheim Securities
Filing attachments
d119865dex107.htm · S-1 · 2026-09-03
EX-10.7
15
d119865dex107.htm
EX-10.7
EX-10.7
Exhibit 10.7
OURA INC.
RESTRICTED
STOCK UNIT AWARD AGREEMENT (NON-PLAN)
Name of Grantee:
No. of Restricted Stock Units:
Grant Date:
Vesting Commencement Date:
Expiration Date:
Pursuant to this Restricted Stock Unit Award Agreement (the “Agreement”), Oura Inc. (the
“Company”) hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. This award is being granted as a stand-alon…
EX-4.1
6
d119865dex41.htm
EX-4.1
EX-4.1
Exhibit 4.1
OURA INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE THIS CERTIFIES THAT SHAREHOLDER NAME (SPECTMEN - NOT
NEGOTTABLE) IS THE REGISTERED HOLDER OF NUMBER OF $HARES (SPECTMEN - NOT NEGOTTABLE) NUMBER SHARES CUSIP: XXXXXXXX FULLY PAID AND NON. ASSESSABLE SHARES OF COMMON STOCK OF $O.OOOOI PAR VALUE OF OURA INC. transferable on the books of the Corporation
only upon surrender of this certificate properly endórsed. This certificate is not…
EX-4.2
7
d119865dex42.htm
EX-4.2
EX-4.2
Exhibit 4.2
OURA INC.
REGISTRATION
RIGHTS AGREEMENT
March 31, 2026
REGISTRATION RIGHTS AGREEMENT
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of the 31st day of March, 2026, by and among Oura Inc., a
Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor.”
RECITALS
WHEREAS, the Company and the Investors desire to enter into a…
EX-99.1
27
d119865dex991.htm
EX-99.1
EX-99.1
Exhibit 99.1
Consent to be Named as a Director Nominee
In connection with the filing by Oura Inc. (the “Company”), of its Registration Statement (the “Registration Statement”) on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as
a nominee to the board of directors of the Company in the Registrat…
EX-99.2
28
d119865dex992.htm
EX-99.2
EX-99.2
Exhibit 99.2
Consent to be Named as a Director Nominee
In connection with the filing by Oura Inc. (the “Company”), of its Registration Statement (the “Registration Statement”) on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as
a nominee to the board of directors of the Company in the Registrat…
